-
Regular Aspirin Use May Help Fight Colorectal Cancer
Aspirin appears to activate an immune response against colorectal cancer in the early stages of the disease.
by Sandra Gordon
-
May 24: The Week in Cancer News
New immunotherapy approved for small cell lung cancer, and researchers investigate using urine tests to detect cancer.
by Kevin McLaughlin
-
May 17: The Week in Cancer News
Disparities in cancer outcomes shrink but persist, and FDA approval increases access to HPV screening.
by Eric Fitzsimmons
-
Progress Against Cancer
New research fuels progress in cancer survival, prevention and side effect management.
-
May 10: The Week in Cancer News
People may be able to wait longer between colonoscopies, and a trial evaluates a less invasive option for treating prostate cancer.
by Thomas Celona
-
Experts Urge Consideration Before Switching Cancer Care Providers
Patients should consider the potential risks, and not just rewards, before changing providers.
by Kyle Bagenstose
-
May 3: The Week in Cancer News
Updated recommendation lowers age for breast cancer screening, and laboratory tests will undergo greater FDA oversight.
by Marci A. Landsmann
-
April 26: The Week in Cancer News
Supplemental breast screenings are not covered by Medicare, and researchers develop a treatment option for a form of eye cancer.
by Kevin McLaughlin
-
Vaccines Spark Activity in Pancreatic Cancer
Scientists thought pancreatic cancer wouldn’t respond to immunotherapy. Now research has found vaccines can trigger the immune system to fight the disease.
by Thomas Celona
-
Navigating Out of Financial Toxicity
People with cancer face an increased risk of financial hardship. Education and expert guidance can offer patients a lifeline.
by Thomas Celona
Cancer Talk
Cancer Today Editors’ Picks: 2024
Our favorite Cancer Today stories from 2024, as picked by the editors.
Rethinking the Role of RadiationChest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona
De-escalating Treatment for DCISResearch finds certain people with low-risk DCIS may be able to forgo surgery or radiation.
by Thomas Celona
Study Highlights Challenges in Pancreatic Cancer StagingMost pancreatic ductal adenocarcinoma cases initially considered to be stage I are changed to a higher stage after surgery.
by Taneia Surles